Nope. None of us are correct until the science is released.

The prospects are incalculable. In vitro testing shows that 50% of all cancers are eradicated by adva-27a. If human trials were to validate these results then adva-27a could be one of the most important drug discoveries of our lives.

People with business knowledge understand that members of the board of directors are never considered employees and act in an advisory role. They have nothing to do with the day to day operations.

Claiming that Merzouki was involved with fraud is willful and malicious character assassination.

No, you claimed Merzouki was an employee. He was put on the Board of Directors for a company in which the employees committed fraud. Merzouki had nothing to do with the fraud, as evidence by the fact that Merzouki was not the target of any investigation.

You are denigrating the man's character maliciously and you should stop imo.

This is false. Board of Director members are not considered employees of the company for which they serve. This is Business 101.

"It ain’t what you don’t know that gets you into trouble. It’s what you know for sure that just ain’t so."

They know that the pandemic is over. They know that omicron is more like a flu.

That does not mean that pl4 is not needed now. There will be more coronaviruses and a non-toxic protease inhibitor will be a solution to other problems. The threat of another deadly coronavirus mutation, while unlikely, is still possible. Pl4 should be a shoe-in for being fast tracked.

Adva-27a, with successful mice trials, is a no-brainer for fast track because of the probable treatment of chemo-resistant pancreatic cancer.

The future is incredibly bright if either get fast tracked. If both make the cut then this company's market cap will be valued in the billions.

We will have to agree to disagree. Good luck to you.

10 to 12 years is average for the development of new drugs in terms of FDA approval. Sunshine is right on time.

Quick math question. Since this is all about the science, let's assume adva-27a is successful in phase 1 human trials.

Let's also assume that the result of this financing with warrants slightly more than doubles the outstanding share count.

Am I better off with 8% of a company worth 25 million or 3.75% of a company worth $5 billion dollars? Maybe some of the experts can help me with that math.

Yes Joe, all that matters is the science. Good luck to us.

Here is your weekly reminder that the share price and the reverse split ratio do not matter. All that matters is whether the science works or not.

There are typically 4 or 5 market makers active on the bid and ask. By active I mean they are in striking distance of consummating a transaction at any time.

Right now there are 6 active MMs on the bid and only 1 active MM on the ask. Something is up I think. As always, I could be wrong. We shall see.

There are 6 markets makers within .005 of the top bid, and only 1 market maker on the ask. Something is going on here, and it is VERY bullish.

Cool story. Let's talk about SBFM in 6 weeks. See you here.

Why? You either trust the company to do the right thing or you don't.

If you don't trust Slilaty, then you should have never bought in. He has always controlled the voting shares. He has always had the ability to do whatever he wants with share structure and dilution.

For the past year, Slilaty has only made moves that signal he respects shareholders. He bought off the toxic financing. He issued himself a respectable number of shares for pay. He and Camille have publicly stated that they will increase shareholder value. He has not pumped the stock one time nor has he diluted us for cash.

If you held your wife to the same standard then you might as well get a divorce. "Sure honey...you have been faithful and loyal to me for all this time but you COULD cheat on me so we have a problem".

I personally find that people who can't trust are the ones who are untrustworthy, but that is just an old man making close to 60 years of observation.

There is nothing to stop Slilaty from screwing us over. There is also no reason to think he will.

Look at Citidel with that fake ask trying to push shares to the other market makers. When the real volume comes, Sunshine's PPS is going to be a space rocket.

The reverse split ratio is MEANINGLESS. All that matters is the science.

That would be a good name for a yacht bought with Sunshine Biopharma money.

....just sayin'.

You talk like caveman.

I holding because of science too.

This is so true. Sunshine will unveil their science and nothing that any of us say now will change the outcome. This will be worth the wait.

"Its Science or Nothing".....when the dust settles I think that should be a t-shirt to commemorate this saga. It perfectly sums up how this will end for SBFM shareholders.

The company has clearly messaged legally about mice studies progressing as planned. Those are in vivo studies.

The average time to complete in vivo studies is indeed 12 to 18 months. That is just a fact.

lol, you don't know this company. You have not talked to them about their philosophy concerning finances. These guys are as cheap as Jack Benny and twice as thrifty.

The discount will be south of 8% because the principals are not going to screw themselves in the process. Wait and see (which is all any of us can do).

You are confusing a drop in price with the discount.

Yes, there is a chance SBFM will fail. If the drugs don't make it to Phase 1, there will be a huge drop in price.

That is a fact about which SBFM investors are acutely aware.

This is why I don't think the mice studies are completed. I think they are holding off the completion so news is not triggered. Dr. Slilaty has been burned badly in the past for sharing information that was stolen by big pharma. He won't make that mistake again.

In vivo studies with mice take 12 to 18 months to complete. To say that the mice studies are past due is incorrect.

You are just wrong about this discount/fee issue- that is crystal clear. ;)

She said 50% to 70% at first. The thing is, she knows the subject well so the question is- why throw out these numbers if you know they aren't true?

nice link combating disinformation.

yes! The notion that the shares will be discounted by 50% is complete ignorance.

The discount will be in the 5% to 8% range.

Now you are backtracking. You now admit that you have no idea what the numbers are and yet you are warning that the result will be failure. You have called this a scam in the past. You threw out discount numbers that are ridiculous.

I do know the discount based on Aegis' history and it will be less than 8%. Aegis is a buyer here. They did over three months of due diligence and they are investing in the company. Their single digit fee is their downside protection.

I have no doubt that you understand the offering process. What you don't understand AT ALL is this particular offering.

We shall see. Sunshine is a high risk/high reward play. I don't discount the risk here but I do think you are attempting to identify types of risk that don't exist for this stock.

Aegis and their affiliates have already committed to buying the offering. It is pre-sold.

With all due respect, I don't think you understand what is occurring with Sunshine.

Actually, after rereading your post, my disagreement with you is semantics.

Whether we call it a fee or a discount, the effect is the same.

The size of the fee/discount will be far less than what you predict though imo and I base this on experience and conversations I have had with people who are closer to this deal than me. Have a good day.

The offering doesn't "fail" for Aegis. They get a percentage of the money raised- and that is a single digit return. You can call that a "discount" but it is in fact a fee. The idea that there will be a 50% to 70% discount to the stock price is silly. All shares bought by Aegis (and they have the right to purchase up to 15% of the float per the S-1) will be bought at market price.

We are playing with the big boys here. This is not the typical stinky pinky transaction that you are used to critiquing.

The S-1 laid down the basic terms. There is no discount post split in this deal. Is the company lying on SEC forms to shareholders?

Some people spend all their time criticizing pink sheet stocks and they are correct 99% of the time. They feel as if they are on top of some social online hierarchy because of this success. They forget that 99% of pink sheet companies have failed business models and that a group of monkeys with computers could be equally correct throwing cyberpoop at the same sample size.

Once a stock is over $5, it is no longer a penny stock. I think there are funds that can't buy now at 5 cents, but would buy at $5 even without a PR.

They understand what Aegis does and they can read Slilaty's resume.

Good discussion, and one truth should be apparent. The price does not matter. The only thing that matters here is the science. When that is revealed we will find out if we are big winners or not. Until then, the daily ups and downs are meaningless.

I heard a rumor that SBFM-PL4 is not really about covid. There are other applications for this new drug that have some people very excited.

Days like today are no different from the days when we drift into the .04s.

The flippers are in control. One of these days we will get news. Real news. It is coming soon imo and the bulls wreak havoc.